loadpatents
Patent applications and USPTO patent grants for Ridgill; Mark Peter.The latest application filed is for "heteroaryl inhibitors of pad4".
Patent | Date |
---|---|
Heteroaryl Inhibitors Of Pad4 App 20210299115 - Devraj; Rajesh ;   et al. | 2021-09-30 |
Heteroaryl inhibitors of PAD4 Grant 11,026,937 - Devraj , et al. June 8, 2 | 2021-06-08 |
Heteroaryl Inhibitors Of Pad4 App 20190358216 - Devraj; Rajesh ;   et al. | 2019-11-28 |
Sepiapterin reductase inhibitors Grant 9,963,462 - Tebbe , et al. May 8, 2 | 2018-05-08 |
Sepiapterin Reductase Inhibitors App 20170096435 - Tebbe; Mark Joseph ;   et al. | 2017-04-06 |
Piperidines and related compounds for the treatment of Alzheimer's disease Grant 8,389,547 - Garcia , et al. March 5, 2 | 2013-03-05 |
Piperidines and related compounds for the treatment of dementia Grant 8,222,418 - Hannam , et al. July 17, 2 | 2012-07-17 |
Piperidine derivatives for treatment of Alzheimer's disease Grant 7,985,758 - Madin , et al. July 26, 2 | 2011-07-26 |
Piperidines And Related Compounds For The Treatment Of Alzheimer's Disease App 20100048623 - Garcia; Yudith ;   et al. | 2010-02-25 |
Piperidines and related compounds for treatment of alzheimer's disease Grant 7,638,629 - Hannam , et al. December 29, 2 | 2009-12-29 |
Piperidines And Related Compounds For The Treatment Of Dementia App 20090239905 - Hannam; Joanne Clare ;   et al. | 2009-09-24 |
Piperidine Derivatives For Treatment Of Alzheimer's Disease App 20090186919 - Madin; Andrew ;   et al. | 2009-07-23 |
Gamma-secretase inhibitors Grant 7,514,459 - Collins , et al. April 7, 2 | 2009-04-07 |
Cyclic sulfamides for inhibition of gamma-secretase Grant 7,427,621 - Collins , et al. September 23, 2 | 2008-09-23 |
Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase Grant 7,371,771 - Castro Pineiro , et al. May 13, 2 | 2008-05-13 |
Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase App 20080070895 - Collins; Ian James ;   et al. | 2008-03-20 |
Piperidines and Related Compounds for Treatment of Alzheimer's Disease App 20080021043 - Hannam; Joanne Clare ;   et al. | 2008-01-24 |
Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase Grant 7,282,513 - Collins , et al. October 16, 2 | 2007-10-16 |
Gamma-secretase inhibitors App 20060293373 - Collins; Ian James ;   et al. | 2006-12-28 |
Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors Grant 7,144,910 - Madin , et al. December 5, 2 | 2006-12-05 |
Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase App 20060173054 - Collins; Ian James ;   et al. | 2006-08-03 |
Cyclic sulfamides for inhibiton of gamma-secretase App 20060135570 - Collins; Ian James ;   et al. | 2006-06-22 |
Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease Grant 7,041,688 - Campbell , et al. May 9, 2 | 2006-05-09 |
Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase Grant 7,041,689 - Collins , et al. May 9, 2 | 2006-05-09 |
Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease App 20050215602 - Campbell, Alister ;   et al. | 2005-09-29 |
Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase App 20050182109 - Collins, Ian James ;   et al. | 2005-08-18 |
Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase App 20050182111 - Pineiro, Jose Luis Castro ;   et al. | 2005-08-18 |
2-aryl indole derivatives and their use as therapeutic agents App 20010039286 - Dinnell, Kevin ;   et al. | 2001-11-08 |
Pyrrolo-pyridine derivatives Grant 5,712,285 - Curtis , et al. January 27, 1 | 1998-01-27 |
Pyrrolo-pyridine derivatives Grant 5,700,809 - Leeson , et al. December 23, 1 | 1997-12-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.